Saluda Medical Pty Ltd
USPTO PatentsView assignee record - 72 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).
The verdict
According to USPTO PatentsView, Saluda ranks #4,837 of 49,997 tracked US assignees by granted-patent volume, with 72 patents across 18 technology areas.
- #4,837
- of 49,997 US assignees by volume
- Top 9%
- by Innovation Score (53.7/100)
- 19.4
- avg claims per patent
- +188%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4837 · Foreign Corporation #4,837 · 72 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 72 grants
- TOP-DECILE #4,837/49,997
- PHOTO-FINISH Shenzhen Guanke
- CPC-FOCUS A61N · 18 areas
- INNOV-PAR 53.7/100
- CLAIMS-RICH 19.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +188% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Shenzhen Guanke Technologies Co., Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Saluda’s 53.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Saluda
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Databricks · near
Databricks · near
54 score
- rewardStyle · near
rewardStyle · near
54 score
- Saluda Medical Pty · this assignee
Saluda Medical Pty · this assignee
54 score
- Shifamed Holdings · near
Shifamed Holdings · near
54 score
- Stellenbosch… · near
Stellenbosch… · near
54 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Saluda's Innovation Score is 53.7/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Saluda?
Each dot is one of Saluda’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Saluda’s own 19.4 claims/patent is ABOVE the 18.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Saluda's grants concentrate
Saluda Medical Pty Ltd is a focused PatentsView assignee: 18 CPC subclasses with 98.6% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (15 grants) versus a trough of 2 in 2017. By volume, Saluda sits between Shenzhen Guanke Technologies Co., Ltd and THE University OF Liverpool.
Saluda's three-year grant acceleration
Saluda Medical Pty Ltd shows 33 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Saluda's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Shenzhen Guanke
Shenzhen Guanke Technologies Co., Ltd
72 patents
- Shire Human Genet…
Shire Human Genetic Therapies, Inc.
72 patents
- Shoei Chemical
Shoei Chemical Inc.
72 patents
- SK Hynix Nand Pro…
SK Hynix Nand Product Solutions Corp.
72 patents
- Sirna Therapeutics
Sirna Therapeutics, Inc.
72 patents
- Sococo
Sococo, LLC
72 patents
- Texas Instruments…
Texas Instruments Deutschland GMBH
72 patents
- THE University OF…
THE University OF Liverpool
72 patents
- Saluda Medical Pty ◀
Saluda Medical Pty Ltd
72 patents
What this shows Saluda holds 72 patents at rank #4,842, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Saluda
By rank, the assignees closest to #4,842 in granted patent volume.
- Shenzhen Guanke Technologies Co., Ltd #4,838 · 72 patents
- Shire Human Genetic Therapies, Inc. #4,839 · 72 patents
- Shoei Chemical Inc. #4,840 · 72 patents
- SK Hynix Nand Product Solutions Corp. #4,841 · 72 patents
- Sirna Therapeutics, Inc. #4,843 · 72 patents
- Sococo, LLC #4,844 · 72 patents
- Texas Instruments Deutschland GMBH #4,845 · 72 patents
- THE University OF Liverpool #4,846 · 72 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in Saluda's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- Zoll Medical Corporation 556 in class
- Koniniklijke Philips N.V. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Saluda, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Saluda ranks #47 of 1,943 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (54 here).
Similar claim depth
Nearest assignees by average claims per patent (19.4 here).
Saluda's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 9% higher than 91% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 5.6% |
| 2016 | 3 | 4.2% |
| 2017 | 2 | 2.8% |
| 2018 | 2 | 2.8% |
| 2019 | 5 | 6.9% |
| 2020 | 5 | 6.9% |
| 2021 | 8 | 11.1% |
| 2022 | 15 | 20.8% |
| 2023 | 5 | 6.9% |
| 2024 | 13 | 18.1% |
| 2025partial year | 10 | 13.9% |
Which technologies does Saluda Medical Pty Ltd patent most?
Top 15 of 18 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Saluda Medical Pty Ltd's patent record in context - here's where to go next.
- Saluda Medical Pty Ltd's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 98.6% of its portfolio - see every assignee active in that class. Explore A61N
- Ranked #4,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Saluda Medical Pty Ltd against Shenzhen Guanke Technologies Co., Ltd, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.